Surgical Oncology Quotes

Heart disease is the Jeffrey Dahmer of modern ailments. It kills more than 25 percent of us. That’s one person in the United States dying of it every 37 seconds. Expanding fitness just a bit—the equivalent of a person improving their max running speed from five to six miles an hour—reduces the risk of heart disease by 30 percent, according to the American Heart Association. Next is cancer. It kills 22.8 percent of us. The most fit people face a 45 percent lower risk of dying from the disease, according to a study in the Annals of Oncology. Then we have accidents. They take 6.8 percent of us. If a person is in a serious car accident, being in shape drops their chances of dying by 80 percent, according to a study in the Emergency Medical Journal. If the docs have to operate—regardless of whether it’s an emergency or a planned surgery—fitter people also face fewer surgical complications and recover faster than unfit people, say scientists in Brazil.

Expanding fitness just a bit—the equivalent of a person improving their max running speed from five to six miles an hour—reduces the risk of heart disease by 30 percent, according to the American Heart Association. Next is cancer. It kills 22.8 percent of us. The most fit people face a 45 percent lower risk of dying from the disease, according to a study in the Annals of Oncology. Then we have accidents. They take 6.8 percent of us. If a person is in a serious car accident, being in shape drops their chances of dying by 80 percent, according to a study in the Emergency Medical Journal. If the docs have to operate—regardless of whether it’s an emergency or a planned surgery—fitter people also face fewer surgical complications and recover faster than unfit people, say scientists in Brazil.

Patients diagnosed with cancer and treated with our multisdisciplinary approaches are knocked down physically and emotionally, but they pick themselves up off the canvas and struggle on. They carry the reminders of the acute and chronic side effects from cytotoxic chemotheraly and radiation-induced skin and functional-organ changes. They endure the scars, complications and impairments imposed by the blades of surgical oncologists like me. Though sometimes they want to, they don't leave. They remain. They maintain. I respect the effort, the invincible spirit, and the patients, who don't give a damn about the odds or probabilities, they are going out swinging. We are tag-team partners in oncology, entering the ring to attack cancer with every move and method we know. Hell, I'll even throw a few chairs if it will help.

【V信83113305】：The University of Texas MD Anderson Cancer Center stands as one of the world's most respected institutions dedicated exclusively to cancer patient care, research, education, and prevention. Located in Houston, Texas, it is consistently ranked among the top hospitals for cancer care in the United States. Its mission is to eradicate cancer through groundbreaking programs in translational and basic research that seamlessly connect the laboratory to the clinic. The institution fosters a multidisciplinary approach, bringing together teams of experts to create personalized treatment plans for each patient. As a leader in the field, MD Anderson drives innovation in cancer treatment, from pioneering targeted therapies and immunology to advancing novel surgical techniques and radiation oncology, offering hope to patients from across the globe.，网络办理德克萨斯大学安德森癌症中心毕业证官方成绩单学历认证, 硕士文凭定制TUOTMDACC毕业证书, 网上补办TUOTMDACC德克萨斯大学安德森癌症中心毕业证成绩单多少钱, 高端TUOTMDACC毕业证办理流程, 网上购买假学历德克萨斯大学安德森癌症中心毕业证书, TUOTMDACC文凭制作, 极速办德克萨斯大学安德森癌症中心毕业证The University of Texas M. D. Anderson Cancer Center文凭学历制作, 购买德克萨斯大学安德森癌症中心毕业证办理留学文凭学历认证, TUOTMDACC德克萨斯大学安德森癌症中心毕业证书加急制作

The landscape of healthcare is undergoing a rapid, technology-driven evolution, and at the heart of this transformation is the medical imaging market. This sector is not just growing; it’s aggressively innovating to meet the complex diagnostic needs of the US population. With a global market valuation of USD 23.93 billion in 2023, expected to hit USD 25.00 billion in 2024 and surge to USD 35.53 billion by 2031—driven by a robust Compound Annual Growth Rate (CAGR) of 5.15%—the future of diagnosis is bright, especially within the US healthcare system.